Intravascular imaging-guided treatment of severe coronary artery calcification with orbital atherectomy: A

L B Yap1, C N Choy2, S Navin2

  • 1Subang Jaya Medical Centre, Department of Cardiology, Subang Jaya, Malaysia. dryaplokbin@gmail.com.

Insights

Orbital atherectomy (OA) effectively treats severe coronary artery calcification, improving stent delivery and expansion. This study found OA to be a safe and successful procedure with no major adverse cardiovascular events in patients with calcified lesions.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Imaging
  • Vascular Interventions

Background:

  • Severe coronary artery calcification complicates percutaneous coronary intervention (PCI).
  • Calcified lesions can impede stent delivery and optimal expansion, leading to suboptimal outcomes.
  • Orbital atherectomy (OA) is a technique to address complex calcified lesions.

Purpose of the Study:

  • To evaluate the procedural success and safety of orbital atherectomy (OA).
  • To assess the efficacy of OA in treating severely calcified coronary lesions.
  • To determine the impact of OA on stent implantation and patient outcomes.

Main Methods:

  • Prospective, single-center study.
  • Utilized intravascular ultrasound (IVUS) or optical coherence tomography (OCT) for lesion characterization and procedural guidance.
  • Primary endpoint: successful stent implantation post-OA. Secondary endpoint: in-hospital and 30-day major adverse cardiovascular events (MACE).

Main Results:

  • Successfully treated 10 patients with severely calcified lesions using OA.
  • Achieved procedural success in all patients, with significant luminal gain (1.3 ± 0.3 mm).
  • No in-hospital or 30-day MACE observed; minor complications (slow flow, dissection) were managed successfully.

Conclusions:

  • Orbital atherectomy is a feasible and safe option for managing calcified coronary stenosis.
  • Intravascular imaging is crucial for assessing calcification, guiding OA, and optimizing stent placement.
  • OA effectively disrupts coronary calcification, facilitating successful stent implantation with favorable outcomes.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
18
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
56
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16